A detailed history of Girard Partners Ltd. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Girard Partners Ltd. holds 27,461 shares of TMO stock, worth $14.1 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
27,461
Previous 31,350 12.41%
Holding current value
$14.1 Million
Previous $18.2 Million 16.66%
% of portfolio
1.44%
Previous 1.72%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$541.52 - $599.02 $2.11 Million - $2.33 Million
-3,889 Reduced 12.41%
27,461 $15.2 Million
Q1 2024

May 13, 2024

BUY
$528.82 - $599.43 $1.56 Million - $1.77 Million
2,954 Added 10.4%
31,350 $18.2 Million
Q4 2023

Feb 09, 2024

SELL
$431.41 - $532.94 $627,270 - $774,894
-1,454 Reduced 4.87%
28,396 $15.1 Million
Q3 2023

Nov 02, 2023

BUY
$498.29 - $574.41 $571,040 - $658,273
1,146 Added 3.99%
29,850 $15.1 Million
Q2 2023

Aug 15, 2023

SELL
$508.46 - $591.13 $157,114 - $182,659
-309 Reduced 1.07%
28,704 $15 Million
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $452,075 - $511,072
845 Added 3.0%
29,013 $16.7 Million
Q4 2022

Jan 26, 2023

BUY
$484.71 - $571.37 $65,435 - $77,134
135 Added 0.48%
28,168 $0
Q3 2022

Oct 20, 2022

BUY
$507.19 - $604.49 $608,628 - $725,388
1,200 Added 4.47%
28,033 $14.2 Million
Q2 2022

Jul 26, 2022

SELL
$500.9 - $612.21 $364,154 - $445,076
-727 Reduced 2.64%
26,833 $14.6 Million
Q1 2022

Apr 27, 2022

BUY
$524.0 - $644.92 $1.93 Million - $2.37 Million
3,679 Added 15.41%
27,560 $16.3 Million
Q4 2021

Feb 02, 2022

BUY
$569.0 - $667.24 $425,043 - $498,428
747 Added 3.23%
23,881 $15.9 Million
Q3 2021

Nov 01, 2021

BUY
$509.53 - $609.78 $5.05 Million - $6.05 Million
9,917 Added 75.03%
23,134 $13.2 Million
Q3 2021

Nov 01, 2021

SELL
$509.53 - $609.78 $4.66 Million - $5.58 Million
-9,143 Reduced 40.89%
13,217 $13.2 Million
Q2 2021

Aug 10, 2021

BUY
$441.0 - $508.24 $2.03 Million - $2.34 Million
4,603 Added 25.92%
22,360 $11.3 Million
Q1 2021

May 06, 2021

BUY
$439.85 - $518.83 $420,496 - $496,001
956 Added 5.69%
17,757 $8.1 Million
Q4 2020

Feb 02, 2021

BUY
$435.06 - $527.66 $79,615 - $96,561
183 Added 1.1%
16,801 $7.83 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $89,582 - $109,938
-249 Reduced 1.48%
16,618 $7.34 Million
Q2 2020

Aug 10, 2020

SELL
$275.2 - $362.34 $205,849 - $271,030
-748 Reduced 4.25%
16,867 $6.11 Million
Q1 2020

May 05, 2020

SELL
$255.3 - $340.05 $130 Million - $174 Million
-510,860 Reduced 96.67%
17,615 $5 Million
Q1 2020

May 01, 2020

BUY
$255.3 - $340.05 $130 Million - $174 Million
510,509 Added 2841.53%
528,475 $5.51 Million
Q4 2019

Feb 03, 2020

SELL
$271.93 - $328.04 $26,105 - $31,491
-96 Reduced 0.53%
17,966 $5.84 Million
Q3 2019

Nov 01, 2019

BUY
$268.46 - $305.43 $34,094 - $38,789
127 Added 0.71%
18,062 $5.26 Million
Q2 2019

Aug 12, 2019

BUY
$257.51 - $295.55 $7,725 - $8,866
30 Added 0.17%
17,935 $5.27 Million
Q1 2019

May 08, 2019

SELL
$212.17 - $273.72 $165,916 - $214,049
-782 Reduced 4.18%
17,905 $4.9 Million
Q4 2018

Feb 11, 2019

SELL
$208.47 - $251.98 $81,720 - $98,776
-392 Reduced 2.05%
18,687 $4.18 Million
Q3 2018

Nov 09, 2018

SELL
$205.57 - $244.32 $264,157 - $313,951
-1,285 Reduced 6.31%
19,079 $4.66 Million
Q2 2018

Aug 07, 2018

BUY
$203.14 - $219.53 $59,113 - $63,883
291 Added 1.45%
20,364 $4.22 Million
Q1 2018

Apr 18, 2018

BUY
$192.98 - $224.11 $61,174 - $71,042
317 Added 1.6%
20,073 $4.14 Million
Q4 2017

Feb 07, 2018

SELL
$182.03 - $200.37 $17,838 - $19,636
-98 Reduced 0.49%
19,756 $3.75 Million
Q3 2017

Nov 08, 2017

BUY
$171.74 - $194.04 $103,902 - $117,394
605 Added 3.14%
19,854 $3.76 Million
Q2 2017

Aug 08, 2017

BUY
N/A
19,249
19,249 $3.36 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.